Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Austria Health Focus.
AskBio Presents Interim Safety Results from Phase 1/Phase 2 LION-CS101 Clinical Trial of AB-1003 in Participants with Limb-Girdle Muscular Dystrophy 2I/R9
Research Triangle Park, N.C., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Data from first cohort of five participants suggest an acceptable safety profile for AB-1003 in participants with limb-girdle muscular dystrophy (LGMD) 2I/R9, with no dose-limiting...
Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial
STAFFORD, Texas, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...
Transit Packaging Market to Surge USD 85.23 Bn by 2032, Smart, Protective Packaging Driving Growth in Pharmaceuticals
Transit Packaging Market size is expected to grow at a CAGR of 4.41% from 2025 to 2032, reaching nearly USD 85.23 billion by 2032. WILMINGTON, DE, UNITED STATES, October 10, 2025 /EINPresswire.com/ -- Explore the booming Transit Packaging...
Metal Cutting Tools Market Drivers 2025-2029: Regional Outlook and Sizing Analysis
The Business Research Company's Metal Cutting Tools Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, November 5, 2025 /EINPresswire.com/ -- Metal Cutting Tools Market Growth...
Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025
DUBLIN and BRIDGEWATER, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today announced it will be presenting new findings at the American Heart...
Premier Alan Winde: Official opening of 12th Regional Leaders’ Summit in Cape Town
Honoured fellow heads of delegation Dr. Markus Söder, Minister-President of Bavaria, Germany Ms. Mary Waters, Chief Administrative Officer of Georgia, USA Mr. Christopher Skeete, Minister of International Relations and La Francophonie, Quebec,...
Owner: South African Government
StoryOne Launches AI-Powered Story Editor to Revolutionize Non-Fiction Publishing
StoryOne launches AI Story Editor enabling anyone to create fact-checked non-fiction books in ~1 hour—up to 300x faster than traditional publishing MARKET HARBOROUGH, UNITED KINGDOM, November 4, 2025 /EINPresswire.com/ -- New platform enables...
Edesa Biotech Announces Upcoming Conference Schedule
TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that Edesa management and...
Datavault AI, Music Dash and NFHITS Partner to Transform Music Data Tracking Display and Monetization Through Patented Inaudible Tones®, AI and Blockchain Technology
PHILADELPHIA, Nov. 03, 2025 (GLOBE NEWSWIRE) -- via IBN – Datavault AI Inc. (Nasdaq: DVLT), a leader in AI-driven data visualization, valuation, and monetization, today announces it has begun collaborating with NFHITS to pioneer a proprietary Web...
Datavault AI, Music Dash and NFHITS Partner to Transform Music Data Tracking Display and Monetization Through Patented Inaudible Tones®, AI and Blockchain Technology
PHILADELPHIA, Nov. 03, 2025 (GLOBE NEWSWIRE) -- via IBN – Datavault AI Inc. (Nasdaq: DVLT), a leader in AI-driven data visualization, valuation, and monetization, today announces it has begun collaborating with NFHITS to pioneer a proprietary Web...
Anti-Inflammatory Drugs Market to Reach USD 274.79 Billion by 2034, Fueled by Rising Innovation and Accessibility
Ottawa, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The global anti-inflammatory drugs market size was valued at USD 122.32 billion in 2024 and is predicted to hit around USD 274.79 billion by 2034, rising at a 8.43% CAGR, a study published by Towards...
DEBRA Research Invests in Eliksa Therapeutics to Advance ELK-003, a Biological Eye Drop for Epidermolysis Bullosa-Related Ocular Complications
The financing supports Eliksa’s clinical development of ELK-003, a biological eye drop for ocular complications in Epidermolysis bullosa (EB) patients. The ongoing pilot study in cooperation with DEBRA Chile has enrolled 18 patients to date, with...
New Global Coalition Launches to Address the Hidden Threat of RSV in Adults
VIENNA, Austria, Oct. 26, 2025 (GLOBE NEWSWIRE) -- A new global coalition, the RSV Alliance, has been launched to raise awareness about the risks of respiratory syncytial virus (RSV) infections, with a focus on aging populations and individuals...
Medela AG Launches «With You, Every Step of the Way» to Celebrate the Everyday Journey of Motherhood
Baar, Switzerland, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Motherhood isn’t one big leap, it’s thousands of small steps: to the pediatrician, to a lactation consultant, to a trusted friend. It’s milk stains and first smiles, it’s sleepless nights and...
STRATA Skin Sciences Announces COFEPRIS Clearance of TheraClear® in Mexico and First Commercial Placements
HORSHAM, Pa., Oct. 28, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a global leader in in-office dermatologic technologies for the treatment of skin conditions such as acne, psoriasis, and vitiligo, today announced that its...
Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe
Initial target markets for commercialization include Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia Expands distributor channel coverage to ~35% of European Union population with ~300,000 annual endovascular...
Amarin Issues Statement Supporting FDA’s Action to Revise Labeling for Fenofibrate Drugs Reinforcing a Lack of Cardiovascular Benefit
DUBLIN and BRIDGEWATER, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular care worldwide, today issued the following statement in response to the recent...
